Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-02-09

Clinical Trial Update: Treatment of Cirrhosis-related Hepatocellular Carcinoma With the Intrahepatic Arterial Injection of an Emulsion of Lipiodol and Idarubicin (Zavedos®): Phase I Study [Phase 1]

View source ↗

Summary

Phase I trial evaluating intrahepatic arterial injection of a Lipiodol and idarubicin emulsion (Zavedos) for unresectable non-metastatic hepatocellular carcinom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lipiodol (Ethiodized oil)
  • Zavedos (idarubicin)

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Unresectable Non-metastatic Hepatocellular Carcinoma, Child A/B7 Cirrhosis | Phase 1 | Status: COMPLETED